PBX2
Basic information
Region (hg38): 6:32184733-32190202
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PBX2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 1 | 0 |
Variants in PBX2
This is a list of pathogenic ClinVar variants found in the PBX2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-32186407-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
6-32186607-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
6-32186639-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
6-32186862-A-G | not specified | Uncertain significance (Jun 21, 2021) | ||
6-32186893-C-T | not specified | Uncertain significance (Apr 08, 2022) | ||
6-32187284-C-A | not specified | Uncertain significance (Oct 03, 2022) | ||
6-32187332-C-T | not specified | Uncertain significance (Aug 04, 2023) | ||
6-32187721-G-A | not specified | Uncertain significance (Jun 23, 2023) | ||
6-32188361-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
6-32188366-G-A | not specified | Uncertain significance (Jun 29, 2022) | ||
6-32188382-C-G | not specified | Uncertain significance (Dec 08, 2023) | ||
6-32189716-C-T | not specified | Uncertain significance (Jun 29, 2022) | ||
6-32189721-G-T | not specified | Uncertain significance (Sep 22, 2022) | ||
6-32189738-T-C | not specified | Uncertain significance (Aug 17, 2022) | ||
6-32189795-T-C | not specified | Likely benign (Aug 26, 2022) | ||
6-32189827-T-C | not specified | Uncertain significance (Feb 24, 2022) | ||
6-32189876-C-A | not specified | Uncertain significance (Sep 20, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PBX2 | protein_coding | protein_coding | ENST00000375050 | 9 | 5452 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.995 | 0.00468 | 125743 | 0 | 4 | 125747 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.84 | 170 | 252 | 0.674 | 0.0000142 | 2761 |
Missense in Polyphen | 34 | 70.397 | 0.48298 | 872 | ||
Synonymous | 2.51 | 67 | 98.8 | 0.678 | 0.00000569 | 862 |
Loss of Function | 3.97 | 1 | 20.3 | 0.0493 | 0.00000107 | 226 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000546 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000202 | 0.0000176 |
Middle Eastern | 0.0000546 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional activator that binds the sequence 5'- ATCAATCAA-3'. Activates transcription of PF4 in complex with MEIS1. {ECO:0000269|PubMed:12609849}.;
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- loftool
- 0.159
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.64
Haploinsufficiency Scores
- pHI
- 0.496
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.537
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.990
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pbx2
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; digestive/alimentary phenotype; hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; skeleton phenotype; immune system phenotype;
Gene ontology
- Biological process
- proximal/distal pattern formation;embryonic limb morphogenesis;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;transcription factor complex
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;chromatin binding;protein binding;transcription factor binding